A. He; T. Spelman; V Jokubaitis; A. Lugaresi; G. Izquiero; M. Trojano; P. Grammond; J. Lechner-Scott; P. Duquette; M. Girard; E. Pucci; M. Slee; F. Grand’Maison; C . Oreja-Guevara; C. Boz; R. Fernandez-Bolanos; S. Hodgkinson; J. Sanchez-Menoyo; G. Iuliano; M. Barnett; F. Moore; H. Butzkueven; T. Kalincik; Ms Base Study Group., Comparison of fingolimod versus interferon-beta/glatiramer acetate as second-line therapy in active multiple sclerosis, «MULTIPLE SCLEROSIS», 2014, 20, pp. 193 - 193 [Abstract]
M. di Ioia; D. Pieragostino; C. Rossi; M. Zucchelli; M. D’Alessandro; A. Lugaresi; D. Travaglini; D. Farina; P. Sacchetta; P. Del Boccio, Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients, «NEUROLOGICAL SCIENCES», 2014, 35, pp. 335 - 335 [Abstract]
A. Bertolotto; F. Marnetto; M. Caldano; A. Lugaresi; M. Spadaro, Effect of Natalizumb treatment on circulating CD4+CD62L+T-cells in multiple sclerosis patients., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 277 - 277 [Abstract]
Bertolotto, A.; Capobianco, M.; Amato, M. P.; Capello, E.; Capra, R.; Centonze, D.; Di Ioia, M.; Gallo, A.; Grimaldi, L.; Imberti, L.; Lugaresi, A.; Mancinelli, C.; Marrosu, M. G.; Moiola, L.; Montanari, E.; Romano, S.; Musu, L.; Paolicelli, D.; Patti, F.; Pozzilli, C.; Rossi, S.; Salvetti, M.; Tedeschi, G.; Tola, M. R.; Trojano, M.; Zaffaroni, M.; Malucchi, S., Erratum: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: Report from the Italian Multiple Sclerosis Study group (Neurological Sciences (2014)), «NEUROLOGICAL SCIENCES», 2014, 35, pp. 1645 - 1646 [Comment or similar]
T. Kalincik; V. Jokubaitis; T. Spelman; D. Horakova; E. Havrdova; M. Trojano; G. Izquierdo; M. Girard; P. Duquette; A. Lugaresi; F. Grand’Maison; P. Grammond; R. Hupperts; C. Oreja-Guevara; E. Pucci; C. Boz; R. Bergamaschi; J. Lechner-Scott; L. Alroughani; V.Van Pesch; G. Iuliano; M. Rio; R. Fernande-Bolanos; C. Ramo; M. Terzi; T. Petersen; M. Slee; D. Spitalieri; MP Amato; F Verheul; E. Cristiano; J. Sanchez-Menoyo; M. Fiol; O. Gray; JA. Cabrera-Gomez; S. Hodgkinson; M. Barnett; M. Saladino; S. Vucic; C. Shaw; F. Moore; E Van Muster; C. Rozsa; P. McCombe; H. Butzkueven, Evaluation of common criteria of progression of disability in a large observational cohort., «MULTIPLE SCLEROSIS», 2014, 20, pp. 62 - 63 [Abstract]
Borreani C; Giordano A; Falautano M; Lugaresi A; Martinelli V; Granella F; Tortorella C; Plasmati I; Radaelli M; Farina D; Dalla Bella E; Bianchi E; Acquarone N; Miccinesi G; Solari A; SIMS-Trial group [ ..; Mattarozzi K; ], Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial., «HEALTH EXPECTATIONS», 2014, 17, pp. 36 - 48 [Scientific article]
Jokubaitis Vg; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Spitaleri Dl; Verheul F; Haartsen J; Liew D; Butzkueven H, Fingolimod after natalizumab and the risk
of short-term relapse, «NEUROLOGY», 2014, 82, pp. 1204 - 1211 [Scientific article]
Lugaresi A; Rottoli MR; Patti F, Fostering adherence to injectable disease-modifying therapies in multiple sclerosis., «EXPERT REVIEW OF NEUROTHERAPEUTICS», 2014, 14, pp. 1029 - 1042 [Scientific article]
Bertolotto A; Capobianco M; Amato MP; Capello E; Capra R; Centonze D; Di Ioia M; Gallo A; Grimaldi L; Imberti L; Lugaresi A; Mancinelli C; Marrosu MG; Moiola L; Montanari E; Romano S; Musu L; Paolicelli D; Patti F; Pozzilli C; Rossi S; Salvetti M; Tedeschi G; Tola MR; Troiano M; Zaffaroni M; Malucchi S, Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 307 - 316 [Scientific article]
Giordano A; Lugaresi A; Confalonieri P; Granella F; Radice D; Trojano M; Martinelli V; Solari A; on behalf of the SIMS-Practice groupa, Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial., «MULTIPLE SCLEROSIS», 2014, 20, pp. 1234 - 1243 [Scientific article]
T. Spelman; C. Meyniel; M. Trojano; A. Lugaresi; G. Izquierdo; F. Grand’Maison; C. Boz; L. Alroughani; E. Havvrdova; G. Iuliano; P. Duquette; M. Terzi; P. Grammond; JA. Cabrera-Gomez; R. Hupperts; J. Lechner-Scott; H. Butzkueven, Indipendent predictors of time to relapse after CIS in high-risk patients., «MULTIPLE SCLEROSIS», 2014, 20, pp. 54 - 54 [Abstract]
D. Pieragostino; M. D’Alessandro; M. di Ioia; M. Zucchelli; A. Lugaresi; P. Sacchetta; P. Del Boccio, Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients., «MULTIPLE SCLEROSIS», 2014, 20, pp. 188 - 189 [Abstract]
A. Ghezzi; C. Pozzilli; L. Moiola; V. Brescia Morra; F. Bortolon; R. Capra; G. Coniglio; M. Filippi; C. Gasperini; L. Grimaldi; R. Lanzillo; G. Lus; A. Lugaresi; N. Milani; L. Prosperini; L. Provinciali; E. Pucci; F. rinaldi; M. Rocca; M. Rottoli; P. Sarchielli; M. Trojano; A. Bianchi; G. Comi, Long term results of natalizumb in the treatment of pediatric MS patients., «NEUROLOGICAL SCIENCES», 2014, 35, pp. 139 - 140 [Abstract]
M. di Ioia; D. Pieragostino; M. D’Alessandro; C. Rossi; M. Zucchelli; A. Lugaresi; V. Di Tommaso; D. Farina; D. Travaglini; P. Sacchetta; P. Del Boccio, Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis., «MULTIPLE SCLEROSIS», 2014, 20, pp. 189 - 190 [Abstract]
Totaro R; Lugaresi A; Bellantonio P; Danni M; Costantino G; Gasperini C; Florio C; Pucci E; Maddestra M; Spitaleri D; Lus G; Ardito B; Farina D; Rossi M; Di Carmine C; Altobelli E; Maccarone B; Casalena A; De Luca G; Travaglini D; Di Ioia M; Di Tommaso V; Fantozzi R; Ruggieri S; Provinciali L; De Riso S; Mundi C; Fuiani A; Galgani S; Ruggieri S; Maniscalco GT; Giuliani G; Cartechini E; Petretta V; Fratta M; Alfieri G; Gatto M; Carolei A; Natalizumab Long-Term Treatment Study group, Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy., «INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY», 2014, 27, pp. 147 - 154 [Scientific article]
